The diagnosis, treatment and overall care needs of breast cancer patients continues to evolve and become more complex. This is due to innovative improvements in therapies, better screening processes, and multidisciplinary care models developing across the US. The indications for axillary node dissection continue to change. Immununotherapy with immune checkpoint blockade is achieving startling results in some patients. There are more options for molecular profiling of tumors, as well as more choices about systemic therapies and radiation therapy. There are more and more long-term survivors who require intelligent management by primary care providers to maintain a high quality of life. At the Ninth Biennial Johns Hopkins Breast Cancer Conference listen, we will learn and actively participate in discussions regarding these topics and more
SSO 2018 will feature an education program that covers, research developments, clinical trials, new technology, and future trends in cancer care. There will be 1,800 attendees, comprised of both academic and community practitioners and healthcare professionals from all surgical oncology specialties.
This meeting will feature scientific presentations, commercial exhibits, and networking opportunities. The meeting expects 1400+ medical professionals, including general surgeons, surgical oncologists, plastic surgeons, radiologists, medical oncologists, and allied health professionals.